SALIM VIRANI to Eicosapentaenoic Acid
This is a "connection" page, showing publications SALIM VIRANI has written about Eicosapentaenoic Acid.
Connection Strength
3.340
-
Highlights of Studies in Cardiovascular Disease Prevention Presented at the 2020 American College of Cardiology Annual Scientific Session. Curr Atheroscler Rep. 2020 06 18; 22(8):32.
Score: 0.659
-
Spotlight on Icosapent Ethyl for Cardiovascular Risk Reduction: Evidence to Date. Vasc Health Risk Manag. 2020; 16:1-10.
Score: 0.639
-
Eligibility and Cost for Icosapent Ethyl Based on the REDUCE-IT Trial. Circulation. 2019 03 05; 139(10):1341-1343.
Score: 0.603
-
Omega-3 Fatty Acid and Cardiovascular Outcomes: Insights From Recent Clinical Trials. Curr Atheroscler Rep. 2019 01 10; 21(1):1.
Score: 0.597
-
What is really new in triglyceride guidelines? Curr Opin Endocrinol Diabetes Obes. 2023 04 01; 30(2):73-80.
Score: 0.198
-
Highlights from Studies in Cardiovascular Disease Prevention Presented at the Digital 2020 European Society of Cardiology Congress: Prevention Is Alive and Well. Curr Atheroscler Rep. 2020 10 03; 22(12):72.
Score: 0.168
-
Triglycerides and ASCVD Risk Reduction: Recent Insights and Future Directions. Curr Atheroscler Rep. 2020 06 03; 22(7):25.
Score: 0.164
-
Cardiovascular Disease Prevention in Focus: Highlights from the 2019 American Heart Association Scientific Sessions. Curr Atheroscler Rep. 2020 01 11; 22(1):3.
Score: 0.160
-
Major Randomized Clinical Trials in Cardiovascular Disease Prevention Presented at the 2019 American College of Cardiology Annual Scientific Session. Curr Atheroscler Rep. 2019 05 24; 21(8):31.
Score: 0.153